Literature DB >> 8773278

Spinal cord ependymoma: a positron emission tomographic study with (11C-methyl)-L-methionine.

T Sasajima1, K Mineura, Y Itoh, M Kowada, J Hatazawa, T Ogawa, K Uemura.   

Abstract

An intramedullary spinal cord ependymoma was studied by positron emission tomography (PET) using (11C-methyl)-L-methionine (11C-Met). MRI showed a homogeneously enhancing tumour at C6-T2 with cysts at its rostral and caudal ends. Sagittal PET images demonstrated high 11C-Met uptake in the solid portion of the tumour, particularly ventrally at C7-T2, where viable tumour cells proliferated in association with abundant perforating vessels. Met-PET would appear useful for delineating the viable portion of intramedullary ependymomas.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8773278     DOI： 10.1007/bf00593221

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  15 in total

1.  Intradural spinal cord lesions: Gd-DTPA-enhanced MR imaging.

Authors:  W P Dillon; D Norman; T H Newton; K Bolla; A Mark
Journal:  Radiology       Date:  1989-01       Impact factor: 11.105

2.  Magnetic resonance and fluorine-18 deoxyglucose imaging in the investigation of a spinal cord tumor.

Authors:  A Alavi; E Kramer; W Wegener; J Alavi
Journal:  J Nucl Med       Date:  1990-03       Impact factor: 10.057

3.  PET evaluation of spinal cord tumor using 11C-methionine.

Authors:  S Higano; F Shishido; M Nagashima; N Tomura; M Murakami; A Inugami; H Fujita; K Tabata; N Yasui; K Uemura
Journal:  J Comput Assist Tomogr       Date:  1990 Mar-Apr       Impact factor: 1.826

4.  Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool.

Authors:  G Di Chiro
Journal:  Invest Radiol       Date:  1987-05       Impact factor: 6.016

5.  Innovative approach in the diagnosis of gliomatosis cerebri using carbon-11-L-methionine positron emission tomography.

Authors:  K Mineura; T Sasajima; M Kowada; Y Uesaka; F Shishido
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

6.  Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.

Authors:  S Leskinen-Kallio; U Ruotsalainen; K Någren; M Teräs; H Joensuu
Journal:  J Nucl Med       Date:  1991-06       Impact factor: 10.057

7.  Intramedullary disease of the spine: diagnosis using gadolinium-DTPA-enhanced MR imaging.

Authors:  G Sze; G Krol; R D Zimmerman; M D Deck
Journal:  AJR Am J Roentgenol       Date:  1988-12       Impact factor: 3.959

8.  Perfusion and metabolism in predicting the survival of patients with cerebral gliomas.

Authors:  K Mineura; T Sasajima; M Kowada; T Ogawa; J Hatazawa; F Shishido; K Uemura
Journal:  Cancer       Date:  1994-05-01       Impact factor: 6.860

9.  Positron emission tomographic evaluation of radiochemotherapeutic effect on regional cerebral hemocirculation and metabolism in patients with gliomas.

Authors:  K Mineura; T Yasuda; M Kowada; T Ogawa; F Shishido; K Uemura
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

10.  Positron emission tomographic evaluation of histological malignancy in gliomas using oxygen-15 and fluorine-18-fluorodeoxyglucose.

Authors:  K Mineura; T Yasuda; M Kowada; F Shishido; T Ogawa; K Uemura
Journal:  Neurol Res       Date:  1986-09       Impact factor: 2.448
View more
  9 in total

1.  Spinal intramedullary metastasis of medulloblastoma at initial diagnosis.

Authors:  Tomoo Inoue; Toshihiro Kumabe; Toshiyuki Takahashi; Takeshi Nakajima; Mika Watanabe; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2006-10-28       Impact factor: 1.475

2.  (18)F-FDG PET-CT for Detection of Recurrent Spinal Ependymoma.

Authors:  Abhinav Singhal; Punit Sharma; Sellam Karunanithi; Bangkim Chandra Khangembam; Suhas Singla; Chandrasekhar Bal; Rakesh Kumar
Journal:  Nucl Med Mol Imaging       Date:  2012-09-28

3.  PET findings of intramedullary tumors of the spinal cord using [18F] FDG and [11C] methionine.

Authors:  N Tomura; Y Ito; H Matsuoka; T Saginoya; S-I Numazawa; Y Mizuno; K Watanabe
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-28       Impact factor: 3.825

Review 4.  Current molecular imaging of spinal tumors in clinical practice.

Authors:  Nora Sandu; Gabriele Pöpperl; Marie-Elisabeth Toubert; Toma Spiriev; Belachew Arasho; Mikael Orabi; Bernhard Schaller
Journal:  Mol Med       Date:  2011-01-03       Impact factor: 6.354

5.  The use of O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of gliomas located in the brainstem and spinal cord.

Authors:  Caroline Tscherpel; Veronika Dunkl; Garry Ceccon; Gabriele Stoffels; Natalie Judov; Marion Rapp; Philipp T Meyer; Elena Rota Kops; Johannes Ermert; Gereon R Fink; Nadim J Shah; Karl-Josef Langen; Norbert Galldiks
Journal:  Neuro Oncol       Date:  2017-05-01       Impact factor: 12.300

Review 6.  Imaging in neurooncology.

Authors:  Andreas H Jacobs; Lutz W Kracht; Axel Gossmann; Maria A Rüger; Anne V Thomas; Alexander Thiel; Karl Herholz
Journal:  NeuroRx       Date:  2005-04

Review 7.  A review on radiogenic Lhermitte's sign.

Authors:  Olga Esik; Tibor Csere; Klára Stefanits; Zsolt Lengyel; Géza Sáfrány; Katalin Vönöczky; Erzsébet Lengyel; Csaba Nemeskéri; Imre Repa; Lajos Trón
Journal:  Pathol Oncol Res       Date:  2003-07-14       Impact factor: 3.201

8.  PET identifies transitional metabolic change in the spinal cord following a subthreshold dose of irradiation.

Authors:  Olga Esik; Miklós Emri; Szabolcs Szakáll; Hans Herzog; Géza Sáfrány; Erzsébet Lengyel; András Boér; Gabriella Liszkay; Lajos Trón; Zsolt Lengyel; Imre Repa
Journal:  Pathol Oncol Res       Date:  2004-03-18       Impact factor: 3.201

9.  Delayed radiation myelopathy: Differential diagnosis with positron emission tomography/computed tomography examination.

Authors:  Tufan Kadir; Feyzi Birol Sarica; Kardes Ozgur; Melih Cekinmez; Altinors Mehmet Nur
Journal:  Asian J Neurosurg       Date:  2012-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.